Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hemopure submitted for U.K. approval

July 12, 2006

JNJ-1250132: A unique progesterone receptor modulator

July 12, 2006

Grant for study of alagebrium effects on renal function in diabetes patients

July 12, 2006

Japanese submission for minodronic acid hydrate in osteoporosis

July 12, 2006

S-2367 shows efficacy in maintaining and continuing weight loss in obese subjects

July 12, 2006

Bremelanotide affects desire and arousal in female sexual arousal disorder patients

July 12, 2006

Iplex shows promise in severe insulin resistance syndromes

July 12, 2006

GTx reports on novel nonsteroidal selective androgen receptor modulators

July 12, 2006

Increlex stability, structural features detailed

July 12, 2006

Preclinical experiments support use of desvenlafaxine for menopause symptoms

July 12, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...